Now I have all the information I need. Let me write the final review.

## Summary

GFMBench introduces an open-source benchmarking framework that standardizes and automates evaluation of Genomic Foundation Models (GFMs). It integrates four large-scale benchmarks (RGB, PGB, GUE, GB) totaling 42 million genomic sequences across 75 datasets, provides unified model/tokenizer wrappers for heterogeneous GFM architectures, and includes an AutoBench pipeline for automated evaluation. The paper demonstrates the framework by benchmarking 10+ open-source GFMs across all four suites, finding that OmniGenome (an RNA-pretrained model with structural information) achieves top-tier performance even on DNA-based tasks.

## Strengths

- **Comprehensive benchmark integration**: GFMBench unifies four previously fragmented benchmark suites (RGB, PGB, GUE, GB) covering both DNA and RNA modalities, spanning 42M sequences and 75 datasets under a single standardized protocol (Section 2.1, Tables 1–4). This aggregation and standardization addresses a real infrastructure gap in genomic evaluation.

- **Unified model/tokenizer wrappers**: The wrapper architecture that standardizes heterogeneous GFMs (Transformers, Hyena, Mamba) with their incompatible tokenizers (k-mer, BPE, SNT) into a unified interface addresses a genuine engineering pain point that hinders cross-architecture comparison (Section 2.1, "Genomic Foundation Models"). The ability to switch between models and benchmark suites with no command modification is a practical contribution.

- **Inclusion of classical baselines**: Table 1 includes classical bioinformatics tools (ViennaRNA, MXfold2, Ufold) alongside neural GFMs, providing important context that many GFM papers omit and enabling meaningful comparison between conventional methods and learned approaches.

- **Cross-modal empirical finding**: The benchmark results reveal that OmniGenome (RNA-pretrained with structural information) achieves top DNA-based PGB performance (F1 of 87.55 on PolyA, 98.41 on Splice Site in Table 2), outperforming DNA-specific models like NT-V2. This cross-modal generalization finding is an interesting empirical observation enabled by the framework's design.

- **Re-implementation of missing evaluation protocols**: For PGB, whose original evaluation protocol was not publicly available, the authors re-implemented the benchmark from scratch (Section 2.1), which is a concrete service to the community.

## Weaknesses

### Fatal

None.

### Major

- **Framework claims are asserted but not empirically validated**: GFMBench claims to address four challenges—data scarcity, metric reliability, reproducibility, and adaptive benchmarking—but Section 3 evaluates models, not the framework itself. There is no demonstration that GFMBench actually improves standardization, reduces metric inconsistencies, or enhances reproducibility relative to existing tools or the status quo. For instance, there is no comparison showing that running a model through GFMBench versus through the original benchmark's native code yields more consistent results. Without such validation, the paper reads as a model comparison study using an unevaluated tool, with the framework contribution remaining unsupported by evidence.

- **EternaV2 results show 0 accuracy for 7/10 models without investigation**: In Table 1, seven out of ten models (DNABERT2, HyenaDNA, Caduceus, NT-V2, Agro-NT, 3UTRBERT, RNABERT) score exactly 0 on EternaV2 accuracy, while OmniGenome scores 84. This pattern across diverse architectures strongly suggests an evaluation incompatibility (tokenizer mismatch, sequence length limit, or output format issue) rather than genuine model failure. The paper does not investigate, acknowledge, or explain this. For a framework whose central promise is standardized and reliable evaluation, having a majority of models score 0 on a task without comment undermines confidence in the benchmarking pipeline.

- **No comparison with existing benchmarking tools**: The related work section names RNABench, GenBench, BEACON, DEGB, and Kipoi as prior systems and claims they "do not prioritise the standardisation and automation of GFM benchmarking" (Section 4), but this claim is never substantiated. There is no qualitative or quantitative comparison showing what GFMBench can do that these tools cannot—particularly notable given that GenBench (Liu et al., 2024) is a very recent effort also targeting GFM benchmarking.

- **Factual inconsistency between text and table**: Section 3.3 states that "OmniGenome also achieves the best performance [on Virus CVC] with an F1 score of 74.72" (line 211), but Table 3 shows the actual value as 64.41. This discrepancy undermines trust in the reported numbers and suggests insufficient proofreading of results.

### Minor

- **Hyperparameter settings are claimed to be frozen but not disclosed**: Section 2.1 states that "We freeze the hyperparameter settings in the standardized benchmark suites" but does not specify what these settings are, whether they are identical across all models or tuned per-model, or how they were chosen. This omission weakens the reproducibility claim, as hyperparameter choice is one of the largest sources of performance variance.

- **Data leakage filtering lacks specificity**: The introduction mentions "data filtering for downstream tasks, e.g., structure predictions, that suffer from data leakage, reducing similar sequences and structures" (line 34), but provides no details on what filtering was done, how similarity was measured, what thresholds were used, or what fraction of data was removed. This is critical for structure prediction tasks where homologous sequences in train/test splits can inflate results.

- **Inconsistent variance reporting**: Only Table 1 reports results "averaged based on five random seeds" (line 134). Tables 2, 3, and 4 report single numbers without standard deviations or number of seeds. For a paper claiming improved metric reliability and reproducibility, this inconsistency is notable.

- **Gene Exp RMSE in PGB shows near-zero discriminative power**: In Table 2, Gene Exp RMSE values range from 14.70 to 15.56 across all 10 models—a range of less than 1 unit on a ~15 RMSE task. The paper does not discuss whether this task meaningfully differentiates models, yet OmniGenome's 14.71 is highlighted as a win.

- **Causal claim about structural information lacks controlled evidence**: The paper repeatedly concludes that "integrating structural information enhances model performance" (Sections 3.1, 3.2, 3.4, 3.5), but this is drawn solely from OmniGenome's relative success—a single-model anecdote. No controlled ablation (e.g., OmniGenome with vs. without structural pretraining) supports this causal inference.

- **Table 4 row label error**: The last row of Table 4 is labeled "GFMbench" instead of "OmniGenome," and the text for Section 3.4 discusses OmniGenome's performance on tasks where only the "GFMbench" row is bolded (e.g., HEE = 82.23). This confusingly places the framework's name where a model name should be.

### Trivial

- The paper uses "GFMbench" and "GFMBench" interchangeably throughout, with inconsistent capitalization.

## Nice-to-Haves

- A reproducibility test: run the same model-dataset pair through GFMBench and through the original benchmark's native code, then compare results.
- Controlled ablation investigating whether structural pretraining specifically drives OmniGenome's cross-modal performance.
- Diagnosis and discussion of the EternaV2 zero-accuracy anomaly.
- Disclosure of exact hyperparameter configurations per model per task.
- Comparison with at least one existing benchmarking tool (e.g., GenBench) on overlapping models/datasets.

## Removed Points

These points are flagged to be removed, treat them with caution.

- *Harsh Critic: "The absence of open-source software for diverse genomics" in the abstract ignores tools like Kipoi.* — The paper cites Kipoi in related work (Section 4) and distinguishes it as an application toolkit rather than a benchmarking tool. The framing is about GFM-dedicated benchmarking software specifically, which is a narrower claim than the harsh critic suggests. However, the abstract's wording is indeed broader than justified.

- *Harsh Critic: "AutoBench for Adaptive Benchmarking" is standard functionality.* — While the name "adaptive" may suggest dynamic intelligence, the paper's actual description (parsing configurations, running models on benchmarks without command modification) is a genuine engineering simplification—unified interfaces across heterogeneous tokenizers and architectures is nontrivial. The contribution is engineering, not algorithmic, which is appropriate for a systems paper.

- *Harsh Critic: The paper is "a model comparison paper wearing a systems paper's clothing."* — This overstates the case. The paper does build and release a software framework with concrete design features (wrapper templates, configuration parsing, leaderboard, online hub). The issue is that the framework's *effectiveness* is not evaluated, not that it doesn't exist. Downgraded to Major weakness.

- *Harsh Critic: Missing appendix/proofs.* — Removed per rules (parser strips appendices).

- *Strength Finder: "Data leakage mitigation" as a strength.* — The paper mentions filtering for data leakage but provides no details (no methodology, thresholds, or results). Moved to Minor weakness instead: a claimed feature without substantiating detail.

- *Strength Finder: "Community infrastructure (leaderboard + online hub)" as a strength.* — The existence of a leaderboard and online hub is noted but these are promised features whose impact cannot be verified from the paper. Kept as a minor supporting strength but not listed as a core strength.

## Novel Insights

The cross-modal finding that OmniGenome (an RNA-structure-pretrained model) achieves top-tier performance on DNA-based plant genomics tasks (PGB) is a non-obvious empirical result. If validated by controlled ablation, it would suggest that RNA secondary structural pretraining captures nucleotide-level patterns generalizable across RNA and DNA modalities—a finding with implications for future GFM pretraining strategies. However, without controlling for other differences (model size, pretraining data, architecture), this finding remains an interesting observation rather than a validated insight.

## Suggestions

- Immediately correct the Virus CVC discrepancy in Section 3.3 (text says 74.72, Table 3 shows 64.41) and the Table 4 "GFMbench" row label.
- Investigate and explain the EternaV2 zero-accuracy results for the 7 models; if the evaluation has incompatibilities, either fix the pipeline or flag the task as currently incompatible with certain model/tokenizer combinations.
- Provide the exact hyperparameter configurations used for each model-task combination (even as supplementary material) to make the reproducibility claim auditable.
- Add a validation experiment: compare results from GFMBench against results produced by the original benchmark suites' native code for at least 2–3 model-task pairs, to demonstrate that the standardization actually works.
- If claiming structural information drives OmniGenome's performance, include even a minimal controlled comparison (e.g., freeze/unfreeze structural encoder on a subset of tasks).

## Evaluation

**Originality**: The paper's primary contribution is an engineering integration of existing benchmarks into a unified framework with standardized wrappers. The cross-modal benchmarking observations are novel but anecdotal. The framework design is practical but not methodologically novel.

**Importance of research question**: Standardizing GFM benchmarking is an important and timely goal given the rapid proliferation of GFMs and the known inconsistencies in evaluation.

**Claims well supported**: Partially. The model comparison results are presented clearly, but several core framework claims (improved reproducibility, metric reliability) are asserted rather than demonstrated. The factual inconsistency between text and Table 3 is concerning.

**Soundness of experiments**: The experiments benchmark models but do not benchmark the framework. Key anomalies (EternaV2 zeros, Gene Exp discriminative power) are not investigated.

**Clarity of writing**: Generally clear, with significant factual errors (Virus CVC number, Table 4 label) that undermine trust.

**Value to community**: The framework fills a real gap if it works as claimed, but the paper does not verify that it does. The open-source release and leaderboard are valuable community contributions.

## Calibration

**Anchors compared:**

| Paper | Path | Avg Score | Comparison |
|-------|------|-----------|------------|
| GeneBench | /home/wg25r/review_agent/human_reviews/0bswm093Yl.md | 4.75 | Very similar: GFM benchmarking paper, model comparison focus, lacks comparison with existing benchmarks, missing details. GFMBench is somewhat better (broader scope covering DNA+RNA, includes classical baselines, has wrapper architecture) but shares the core weakness of not validating its framework |
| DGEB | /home/wg25r/review_agent/human_reviews/fopjVghcE2.md | 5.50 | Similar genomic embedding benchmark, scored 5.5 despite better analysis depth. GFMBench has more comprehensive model coverage but weaker analytical depth |
| Genomics LRB | /home/wg25r/review_agent/human_reviews/8O9HLDrmtq.md | 5.00 | DNA LM benchmark with meaningful long-range tasks, scored 5. GFMBench has broader coverage but LRB has deeper analysis |
| ProteinBench | /home/wg25r/review_agent/human_reviews/BksqWM8737.md | 6.50 | Accepted poster—holistic protein evaluation with taxonomic task classification and multi-metric evaluation. More thorough than GFMBench, validates framework through analysis depth |
| WildBench | /home/wg25r/review_agent/human_reviews/MKEHCx25xp.md | 7.33 | High-scoring benchmark paper with validated framework claims, correlation with human judgments. Clear gap from GFMBench which lacks framework validation |
| FaL6aTuXod (low anchor) | /home/wg25r/review_agent/human_reviews/FaL6aTuXod.md | 1.50 | Purely derivative benchmarking framework with no novelty. GFMBench is clearly well above this |

GFMBench is closest in quality to GeneBench (4.75) and Genomics LRB (5.0). It's slightly better than GeneBench due to broader coverage (DNA+RNA), inclusion of classical baselines, and the wrapper architecture, but shares the fundamental weakness of not validating the framework. It's below ProteinBench (6.5) and well below WildBench (7.33) which actually validate their evaluation frameworks. The factual inconsistency and unexplained EternaV2 zeros further weaken it.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>